Telbivudine and muscular weakness Patient Reports February 11, 2012

Telbivudine Side Effects Report #5585729-4
Telbivudine side effect was reported by a Physician from SINGAPORE on Jan 04, 2008. Female patient, 64 years of age, was diagnosed with hepatitis b , hypertension and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase decreased, blood creatine phosphokinase increased, intervertebral disc disorder, muscular weakness, myopathy, neuropathy peripheral. Telbivudine dosage: 600 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EVENING PRIMROSE OIL, ATENOLOL, ENALAPRIL, LOSARTAN POTASSIUM, NIFEDIPINE. Patient recovered.

Telbivudine Side Effects Report #5597494-5
Telbivudine side effect was reported by a Physician from SINGAPORE on Jan 17, 2008. Female patient, 64 years of age, was diagnosed with hepatitis b , hypertension and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase decreased, blood creatine phosphokinase increased, intervertebral disc disorder, muscular weakness, myopathy, myositis , neuropathy peripheral. Telbivudine dosage: 600 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EVENING PRIMROSE OIL, ATENOLOL, ENALAPRIL MALEATE, LOSARTAN, NIFEDIPINE. Patient recovered.

Telbivudine Side Effects Report #5669319-0
Telbivudine side effect was reported by a Physician from SINGAPORE on Mar 07, 2008. Male patient, 64 years of age, was diagnosed with hepatitis b , hypertension and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, intervertebral disc disorder, muscular weakness, myopathy, myositis , neuropathy peripheral. Telbivudine dosage: 600 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EVENING PRIMROSE OIL, ATENOLOL, ENALAPRIL MALEATE, LOSARTAN POTASSIUM, NIFEDIPINE. Patient recovered.

Telbivudine Side Effects Report #5711753-4
Telbivudine side effect was reported by a Physician from SINGAPORE on Apr 10, 2008. Male patient, 64 years of age, was diagnosed with hepatitis b , hypertension and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, intervertebral disc disorder, muscular weakness, myopathy, myositis , neuropathy peripheral. Telbivudine dosage: 600 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EVENING PRIMROSE OIL, ATENOLOL, ENALAPRIL MALEATE, LOSARTAN POTASSIUM, NIFEDIPINE. Patient recovered.


Telbivudine Side Effects Report #5724746-8
Telbivudine side effect was reported by a Physician from SINGAPORE on Apr 22, 2008. Male patient, 64 years of age, was diagnosed with hepatitis b , hypertension and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, intervertebral disc disorder, muscular weakness, myopathy, myositis , neuropathy peripheral. Telbivudine dosage: 600 MG,. During the same period patient was treated with HYDROCHLOROTHIAZIDE, EVENING PRIMROSE OIL, ATENOLOL, ENALAPRIL, LOSARTAN POTASSIUM, NIFEDIPINE, LECITHIN, GLUCOSAMINE. Patient recovered.

Telbivudine Side Effects Report #5646624-5
Telbivudine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 20, 2008. Male patient, 56 years of age, was diagnosed with hepatitis b  and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: demyelinating polyneuropathy, hypoaesthesia, limb discomfort, muscle atrophy, muscular weakness, musculoskeletal pain, myalgia, myopathy, polymyositis. Telbivudine dosage: 600 MG,. Patient was hospitalized. Patient recovered.

Telbivudine Side Effects Report #5669613-3
Telbivudine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Mar 06, 2008. Male patient, 56 years of age, was diagnosed with hepatitis b  and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: demyelinating polyneuropathy, hearing impaired, hypoaesthesia, limb discomfort, muscle atrophy, muscular weakness, musculoskeletal pain, myalgia, myopathy. Telbivudine dosage: 600 MG,. Patient was hospitalized. Patient recovered.

Telbivudine Side Effects Report #5815961-3
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 45 years of age, was diagnosed with hepatitis b , hepatic cirrhosis and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypersplenism, hypoaesthesia, muscular weakness, musculoskeletal pain, myalgia, myopathy, neuralgia. Telbivudine dosage: 600 MG, BID. Patient recovered.

Telbivudine Side Effects Report #5815964-9
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 37 years of age, was diagnosed with hepatitis b  and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with INTERFERON. Patient recovered.


Telbivudine Side Effects Report #5815993-5
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 35 years of age, was diagnosed with hepatitis b  and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient recovered.

Telbivudine Side Effects Report #5815978-9
Telbivudine side effect was reported by a Health Professional from CHINA on July 09, 2008. Male patient, 30 years of age, was diagnosed with hepatitis b  and was treated with Telbivudine. After drug was administered, patient experienced the following side effects: arrhythmia , blood creatine phosphokinase increased, hypoaesthesia, muscular weakness, myalgia, neuralgia. Telbivudine dosage: 600 MG, QD. During the same period patient was treated with INTERFERON. Patient recovered.